AzTrials
AzTrials

Postoperative ComplicationsREMAIN-1NCT05556174

Intraoperative Lung Protective Ventilation Needs Periodic Lung Recruitment Maneuvers

A study testing periodic lung recruitment maneuvers in people with Postoperative Complications and Abdominal Surgery, run by Sixth Affiliated Hospital, Sun Yat-sen University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Postoperative Pulmonary Complications (PPC) are common. It severely affects postoperative recovery, particularly in abdominal surgery. Several studies showed that intraoperative lung-protective ventilation with periodic lung recruitment maneuvers could reduce postoperative pulmonary complications. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
periodic lung recruitment maneuvers
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,060 participants
Where
1 siteChina
Study dates
9 Oct 2022to 11 Nov 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Undergoing elective major abdominal surgery (expected duration of mechanical ventilation ≥2 h)
  • had an intermediate to high risk of developing postoperative pulmonary complications as indicated by an Assess Respiratory Risk in Surgical Patients in Catalonia score (≥26)
  • Pulse oxygen saturation in room air ≥ 94%

Who cannot join

  • younger than 18 years
  • had received invasive mechanical ventilation for longer than 1 h within the last 2 weeks prior to surgery
  • had a history of pneumonia within 1 month prior to surgery
  • had severe chronic obstructive pulmonary disease or pulmonary bullae
  • had a progressive neuromuscular illness
  • severe heart dysfunction (New York Heart Association classification ≥4)
Show all 10Show fewer
  • with an American Society of Anesthesiologists (ASA) physical status of IV or higher
  • Intracranial hypertension
  • were pregnant (excluded by laboratory analysis)
  • were involved in other interventional studies

Trial locations and contacts

1 site in 1 country.

China1 site
  • The Sixth Affiliated Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, 510655

Other trials in China

About this study

Official title: Intraoperative Lung Protective Ventilation With or Without Periodic Lung Recruitment Maneuvers on Pulmonary Complications After Major Abdominal Surgery: a Prospective Randomized Controlled Study

Postoperative Pulmonary Complications (PPC) are common. It severely affects postoperative recovery, particularly in abdominal surgery. Several studies showed that intraoperative lung-protective ventilation with periodic lung recruitment maneuvers could reduce postoperative pulmonary complications. Other studies showed that intraoperative lung protective ventilation without periodic lung recruitment maneuvers could also reduce postoperative pulmonary complications. The purpose of this study was to compare the effects of the above two regimens on postoperative pulmonary complications.

Being tested
periodic lung recruitment maneuvers
Medical subject headings
Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • periodic lung recruitment maneuversOther

    lung recruitment maneuvers repeated every 30 minutes

Study groups in NCT05556174
Study groupRoleWhat they receive
Intensive intraoperative lung-protective ventilationExperimentalintraoperative lung-protective ventilation with periodic lung recruitment maneuvers
Receives: Other: periodic lung recruitment maneuvers
Moderate intraoperative lung-protective ventilationNo interventionintraoperative lung-protective ventilation without periodic lung recruitment maneuvers

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of respiratory failure

    Respiratory failure: postoperative arterial partial pressure of oxygen (PaO2) < 8 kPa (60 mmHg) on room air, a PaO2: Inhaled oxygen concentration (FI02) ratio < 40 kPa (300 mmHg) or arterial oxyhaemoglobin saturation measured with pulse oximetry < 90% and requiring oxygen therapy

    Measured: Day 0 to 7 after surgery

Secondary outcomes (25)
  1. Rate of mild respiratory failure

    Mild respiratory failure: PaO2 < 60 mmHg or pulse oxygen saturation (SpO2) < 90% on room air, but SpO2 can be raised to more than 90% when inhaling oxygen through nasal catheter less than 3 L/min.

    Measured: Day 0 to 7 after surgery

  2. Rate of moderate respiratory failure

    Moderate respiratory failure: PaO2 < 60 mmHg or SpO2 < 90% when inhaling oxygen through nasal catheter less than 3 L/min, but SpO2 can be raised to more than 90% when inhaling oxygen more than 3 L/min.

    Measured: Day 0 to 7 after surgery

  3. Rate of severe respiratory failure

    Severe respiratory failure: experienced an invasive or noninvasive ventilator therapy, or PaO2 < 60 mmHg or SpO2 < 90% when administering oxygen via a nasal catheter at 3 L/min or more.

    Measured: Day 0 to 7 after surgery

  4. Rate of sustained hypoxaemia

    Sustained hypoxaemia: during a follow-up visit when the patient was awake and breathing room air, SpO2 ≤ 92% or the change of SpO2 (ΔSpO2, preoperative SpO2 minus postoperative SpO2) ≥ 5% on any three consecutive days.

    Measured: Day 0 to 7 after surgery

  5. Rate of modified respiratory failure

    Modified respiratory failure: met the criterion of moderate or severe respiratory failure, or mild respiratory failure in twice follow-up, or mild respiratory failure with sustained hypoxemia.

    Measured: Day 0 to 7 after surgery

  6. Rate of respiratory infections

    Respiratory infections: receiving antibiotics for a suspected respiratory infection and met at least one of the following criteria: new or changed sputum, new or changed lung opacities, fever, leukocyte count >12 × 109 /L

    Measured: Day 0 to 7 after surgery

  7. Rate of pneumonia

    Pneumonia: United States Centers for Disease Control definition of pneumonia

    Measured: Day 0 to 7 after surgery

  8. Rate of aspiration pneumonitis

    Aspiration pneumonitis: acute lung injury after the inhalation of regurgitated gastric contents.

    Measured: Day 0 to 7 after surgery

  9. Rate of pneumothorax

    Pneumothorax: air in the pleural space with no vascular bed surrounding the visceral pleura

    Measured: Intraoperative or day 0 to 7 after surgery

  10. Rate of pleural effusion

    Pleural effusion: chest radiograph demonstrating blunting of the costophrenic angle, loss of sharp silhouette of the ipsilateral hemidiaphragm in upright position, evidence of displacement of adjacent anatomical structures or (in supine position) a hazy opacity in one hemithorax with preserved vascular shadows

    Measured: Day 0 to 7 after surgery

  11. Rate of Acute Respiratory Distress Syndrome

    Acute Respiratory Distress Syndrome: The Berlin definition of Respiratory Distress Syndrome

    Measured: Day 0 to 7 after surgery

  12. Rate of Quick Sequential Organ Failure Assessment (qSOFA) ≥ 2

    qSOFA ≥ 2: Two or more of: Respiratory rate ≥22/min, Altered mentation, Systolic blood pressure ≤ 100 mm Hg

    Measured: Day 0 to 7 after surgery

  13. Rate of Systemic Inflammatory Response Syndrome (SIRS)

    SIRS: Two or more of: Temperature >38°C or <36°C, Heart rate > 90/min, Respiratory rate >20/min or PaCO2<32 mmHg (4.3kPa), White blood cell count >12 000/mm3 or 10% immature bands

    Measured: Day 0 to 7 after surgery

  14. Rate of Major Adverse Cardiac and Cerebrovascular Events (MACCE)

    MACCE: Stroke, coma, non-fatal cardiac arrest, acute myocardial infarction, congestive heart failure.

    Measured: Day 0 to 7 after surgery

  15. Postoperative hospitalization days

    The duration between the operation date and the actual discharge date, days

    Measured: Day 0 to 30 after surgery

  16. Rate of Unexpected admission to intensive care unit (ICU)

    Unexpected admission to ICU: It does not include patients who enter ICU at the request of surgeons but have normal spontaneous breathing, stable circulation and no disturbance of consciousness.

    Measured: Day 0 to 30 after surgery

  17. Rate of death

    Death from any cause

    Measured: Day 0 to 30 after surgery

  18. Rate of intraoperative hypotension

    Intraoperative hypotension: mean arterial pressure (MAP) < 60 mmHg lasting more than 3 minutes

    Measured: Intraoperative, period of mechanical ventilation

  19. Rate of intraoperative needing for vasoconstrictor

    Intraoperative vasoconstrictor needs: MAP < 60 mmHg and using any catecholamines

    Measured: Intraoperative, period of mechanical ventilation

  20. Rate of intraoperative hypoxemia

    Intraoperative hypoxemia: SpO2 ≤ 92% lasting more than 3 minutes

    Measured: Intraoperative, period of mechanical ventilation

  21. Rate of Intraoperative bradycardia

    Intraoperative bradycardia: heart rate ≤ 50 bpm and the decrease of heart rate from the basic value ≥ 20% lasting more than 3 minutes

    Measured: Intraoperative, period of mechanical ventilation

  22. Rate of post-anesthesia care unit respiratory failure

    Post-anesthesia care unit respiratory failure: PaO2 < 8 kPa (60 mmHg) on room air, a PaO2:FI02 ratio < 40 kPa (300 mmHg) or arterial oxyhaemoglobin saturation measured with pulse oximetry < 90% and requiring oxygen therapy

    Measured: Postoperative, during postanesthesia care unit

  23. Intraoperative mechanical power

    Mechanical power, J/min

    Measured: Intraoperative: after half an hour of mechanical ventilation, before the end of mechanical ventilation

  24. PaO2 / FI02

    PaO2 / FI02, mmHg

    Measured: Intraoperative: after half an hour of mechanical ventilation, before the end of mechanical ventilation

  25. Postoperative pulmonary complications score

    Postoperative pulmonary complications score: graded on a scale from 0 (no pulmonary complications) to 4 (the most severe complications).

    Measured: Day 0 to 7 after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Sep 2022
  2. Study start9 Oct 2022
  3. Primary completion11 Sep 2024
  4. Study completion11 Nov 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
1,060 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05556174
Sponsor's protocol ID
2022ZSLYEC-398
Acronym
REMAIN-1
Status last verified
Nov 2024
First submitted
14 Sep 2022
Last updated
3 Jan 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Zhang NR, Zhang LZ, Chen Y, Zhang S, Li S, Gu XK, Li J, Li H. Intraoperative protective ventilation with or without periodic lung recruitment manoeuvres on pulmonary complications after major abdominal surgery (REMAIN-1): protocol for a randomised controlled trial. BMJ Open. 2025 Mar 13;15(3):e093360. doi: 10.1136/bmjopen-2024-093360.

    PubMed 40082005

Questions about this trial

What is this clinical trial studying?

A study testing periodic lung recruitment maneuvers in people with Postoperative Complications and Abdominal Surgery, run by Sixth Affiliated Hospital, Sun Yat-sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of respiratory failure (time frame: Day 0 to 7 after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05556174, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in